Go to content
UR Home

FGFR3 Mutation, Tumorangiogenese und klinisches Outcome in Urothelkarzinomen

Abée, Christine (2014) FGFR3 Mutation, Tumorangiogenese und klinisches Outcome in Urothelkarzinomen. PhD, Universität Regensburg.

[img]
Preview
License: Publishing license for publications excluding print on demand
PDF
Download (14MB)
Date of publication of this fulltext: 27 Mar 2014 14:28

Abstract (German)

Der Fibroblastenwachstumsfaktor-Rezeptor 3 (FGFR 3) spielt eine wichtige Rolle in der Pathogenese von Urothelkarzinomen und ist zudem ein wichtiger Mediator der Tumorangiogenese. Der Mechanismus der Tumorangiogenese ist ein komplexer Vorgang der hauptsächlich von Tyrosinkinaserezeptoren der Vascular Endothelial Growth Faktoren Familie (VEGF) reguliert wird. In der vorliegenden Arbeit wurde daher ...

plus

Translation of the abstract (English)

Fibroblast Growth Factor receptor tyrosine kinase 3 (FGFR 3) plays an important role in the pathogenesis of urothelial bladder cancer and is also involved in tumour angiogenesis. Tumour angiogenesis is a complex mechanism, which is mainly regulated by receptor tyrosine kinases of the Vascular Endothelial Growth Factor (VEGF) family. Thus, this study investigated the relation of tumour ...

plus


Export bibliographical data



Item type:Thesis of the University of Regensburg (PhD)
Date:27 March 2014
Referee:PD Dr. Andreas Gaumann
Date of exam:7 February 2014
Institutions:Medicine > Lehrstuhl für Pathologie
Keywords:tumour, angiogenesis, FGFR3, microvessel density, Urothelkarzinom, Angiogenese
Dewey Decimal Classification:600 Technology > 610 Medical sciences Medicine
Status:Published
Refereed:Yes, this version has been refereed
Created at the University of Regensburg:Yes
Item ID:29603
Owner only: item control page

Downloads

Downloads per month over past year

  1. Homepage UR

University Library

Publication Server

Contact:

Publishing: oa@ur.de

Dissertations: dissertationen@ur.de

Research data: daten@ur.de

Contact persons